October 2017 FDA Recall Drug by Sanofi-aventis U.s. Llc
D-0056-2018 - Labeling

This Class III drug recall was voluntarily initiated by Sanofi-aventis U.s. Llc on October 13, 2017 for the product Drug. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0056-2018

Reason for Recall
Labeling: Incorrect or Missing Package Insert: authorized generic product was packaged with the incorrect insert for the brand name product Clolar (clofarabine) injection.
Initiated
10-13-2017
Reported
11-08-2017
Quantity
422 vials

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Sanofi-Aventis U.S. LLC
Nationwide in the USA
Clofarabine injection, 20 mg/20 mL, 20 mL Single-Use Vial, Rx only, Mfd by: Teva Pharmachemle, Swensweg 5, Haarlem, The Netherlands; Mfd for: Winthrop U.S., a business of sanofi-aventis U.S. LLC, Bridgewater, NJ 08807; NDC 0955-1746-01.

Batch or Lot Expiration Information

Lot# : K5006Y02, Exp 31AUG18